# Ifosfamide (Ifosfamide for Injection) by SteriMax Inc.: new human prescription drug listing

**Launch Signal Score:** 50/100

| Field | Value |
|---|---|
| Product | Ifosfamide |
| Generic name | Ifosfamide for Injection |
| NDC | 21586-211 |
| Labeler | SteriMax Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Dosage form | POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active ingredients | IFOSFAMIDE 1 g/1 |
| Pharmacologic class | Alkylating Drug [EPC] |
| Marketing start | 2026-09-04 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.
- Injectable: hospital and 503B relevance.
- Class: Alkylating Drug [EPC].

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=21586-211). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.